Ownership Summary
Adicet Bio, Inc. (NASDAQ:ACET) has 1 institutional investors that have filed 13F reports for the period ending March 2026.
- These investors collectively held 0.6% of Adicet Bio's outstanding shares in March 2026, down from 0.9% in December 2025.
- They maintained total shares held in Adicet Bio by 0.0% from the prior quarter, while the number of investors in ACET decreased 98.25% year over year.
- Of these 1 funds, 0 grew their exposure to Adicet Bio, 0 cut back, and 1 maintained positions.
- Combined, these investors held 60.51K shares in ACET for March 2026, with no net change quarter on quarter, and down 3.91Mn shares year over year.
- Regeneron Pharmaceuticals, Inc. leads ownership in ACET with 60.51K shares as of March 31, 2026, equal to 0.56% of outstanding shares.
- According to Business Quant data, leading holders of ACET for March 2026 are Regeneron Pharmaceuticals, Inc. (60.51K).